8GIH

Structure of Hepatitis B Virus Capsid Y132A mutant in complex with Compound 24


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free: 0.253 
  • R-Value Work: 0.205 
  • R-Value Observed: 0.208 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history


Literature

Diazepinone HBV capsid assembly modulators.

Kuduk, S.D.DeRatt, L.G.Stoops, B.Shaffer, P.Lam, A.M.Espiritu, C.Vogel, R.Lau, V.Flores, O.A.Hartman, G.D.

(2022) Bioorg Med Chem Lett 72: 128823

  • DOI: https://doi.org/10.1016/j.bmcl.2022.128823
  • Primary Citation of Related Structures:  
    8GIH

  • PubMed Abstract: 

    The HBV capsid core protein serves a number of important functions in the viral life cycle enabling chronic HBV infection to persist, and therefore is a promising drug target. Interfering with capsid assembly has shown efficacy in clinical trials with small molecule capsid assembly modulators (CAMs). Herein is described the further optimization of a progressive series of diazepinone HBV CAMs.


  • Organizational Affiliation

    Janssen Research and Development, 1400 McKean Road, Spring House, PA 19477, United States. Electronic address: skuduk@its.jnj.com.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Capsid protein
A, B, C, D, E
A, B, C, D, E, F
160Hepatitis B virusMutation(s): 1 
Gene Names: C
UniProt
Find proteins for L7R9I1 (Hepatitis B virus)
Explore L7R9I1 
Go to UniProtKB:  L7R9I1
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupL7R9I1
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
ZMH (Subject of Investigation/LOI)
Query on ZMH

Download Ideal Coordinates CCD File 
I [auth A]
K [auth B]
O [auth C]
R [auth D]
U [auth E]
I [auth A],
K [auth B],
O [auth C],
R [auth D],
U [auth E],
X [auth F]
(6S,8R)-N-(3-bromo-4-fluorophenyl)-8-fluoro-10-methyl-11-oxo-1,3,4,7,8,9,10,11-octahydro-2H-pyrido[4',3':3,4]pyrazolo[1,5-a][1,4]diazepine-2-carboxamide
C18 H18 Br F2 N5 O2
HKVGNSIAARSCKF-SNVBAGLBSA-N
CL
Query on CL

Download Ideal Coordinates CCD File 
G [auth A]
H [auth A]
J [auth B]
L [auth C]
M [auth C]
G [auth A],
H [auth A],
J [auth B],
L [auth C],
M [auth C],
N [auth C],
P [auth D],
Q [auth D],
S [auth E],
T [auth E],
V [auth F],
W [auth F]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free: 0.253 
  • R-Value Work: 0.205 
  • R-Value Observed: 0.208 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 151.78α = 90
b = 87.57β = 103.48
c = 103.26γ = 90
Software Package:
Software NamePurpose
XDSdata reduction
XSCALEdata scaling
PHENIXrefinement
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2023-04-12
    Type: Initial release
  • Version 1.1: 2023-10-25
    Changes: Data collection, Refinement description